Get With The Guidelines-Heart Failure Registry

American Heart Association (AHA)

Status

Enrolling

Conditions

Heart Failure

Treatments

Other: GWTG Heart Failure program

Study type

Observational

Funder types

Other

Identifiers

NCT02693509

GWTG01

Details and patient eligibility

About

Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Full description

Get With The Guidelines-Heart Failure was initiated in 2005 with over 500 U.S. hospitals participating is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Peer-reviewed research(with over 35 manuscripts) has demonstrated that through participating in Get With The Guidelines-Heart Failure, hospitals will provide equitable care (regardless of race, ethnicity, age, or gender), the importance of scheduled physician follow-up after heart failure hospital discharge, the value in device-support as necessary for the acute heart failure patient, and many other significant findings.

Achievement measures tracked through Get With The Guidelines-Heart Failure:

Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) at discharge
Evidence-based specific beta blockers
Measure left ventricular function
Post-discharge appointment for heart failure patients

Quality Measures tracked through Get With The Guidelines-Heart Failure:

Mineralocorticoid receptor antagonist at discharge
Aldosterone antagonist at discharge
Anticoagulation for atrial fibrillation
Hydralazine nitrate at discharge
DVT prophylaxis
CRT-D or CRT-P placed or prescribed at discharge
ICD counseling, or ICD placed or prescribed at discharge
Influenza vaccination during flu season
Pneumococcal vaccination
Follow-up visit within 7 days or less
Lab monitoring follow-up
SGLT-2 inhibitor at discharge
Defect-free care for quadruple therapy medication for patients with heart failure with reduced ejection fraction
Direct-acting oral anticoagulant at discharge for non-valvular atrial fibrillation or atrial flutter patients

Additional measures collected by Get With The Guidelines-Heart Failure can be viewed at: http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/@gwtg/documents/downloadable/ucm_310967.pdf

Enrollment

128,026 estimated patients

Sex

All

Ages

18 to 125 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria